Single gel application may speed healing of diabetic foot wounds

NCT ID NCT07206862

Not yet recruiting Disease control Sponsor: DEBx Medical B.V. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a gel called DEBRICHEM® that is applied once to chronic diabetic foot ulcers to remove biofilm and help the wound heal. About 242 adults with foot ulcers that have not improved for at least 4 weeks will be randomly assigned to receive standard wound care plus the gel or standard care alone. The main goal is to see if more people achieve complete wound healing by 20 weeks with the gel.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DEBRICHEM® (a desiccant gel applied once to chemically debride the wound)
What this could lead to: If it works, this gel could help diabetic foot ulcers heal faster and reduce the risk of infection, hospitalization, or amputation.
What could go wrong: This is an early-stage trial with no phase designation, so results are uncertain. The gel is applied only once, and its benefit over standard care alone is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER (DFU) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT ULCER (DFU) DIABETIC FOOT ULCER TREATMENT DIABETIC FOOT WOUNDS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.